BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 20420834)

  • 21. The up-regulation of voltage-gated sodium channels subtypes coincides with an increased sodium current in hippocampal neuronal culture model.
    Guo F; Xu X; Cai J; Hu H; Sun W; He G; Shao D; Wang L; Chen T; Shaw C; Zhu T; Hao L
    Neurochem Int; 2013 Feb; 62(3):287-95. PubMed ID: 23333592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First mutation in the voltage-gated Nav1.1 subunit gene SCN1A with co-occurring familial hemiplegic migraine and epilepsy.
    Castro MJ; Stam AH; Lemos C; de Vries B; Vanmolkot KR; Barros J; Terwindt GM; Frants RR; Sequeiros J; Ferrari MD; Pereira-Monteiro JM; van den Maagdenberg AM
    Cephalalgia; 2009 Mar; 29(3):308-13. PubMed ID: 19220312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe epilepsy syndromes of early childhood: the link between genetics and pathophysiology with a focus on SCN1A mutations.
    Stafstrom CE
    J Child Neurol; 2009 Aug; 24(8 Suppl):15S-23S. PubMed ID: 19666879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generalized epilepsy with febrile seizures plus-associated sodium channel beta1 subunit mutations severely reduce beta subunit-mediated modulation of sodium channel function.
    Xu R; Thomas EA; Gazina EV; Richards KL; Quick M; Wallace RH; Harkin LA; Heron SE; Berkovic SF; Scheffer IE; Mulley JC; Petrou S
    Neuroscience; 2007 Aug; 148(1):164-74. PubMed ID: 17629415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular properties of brain sodium channels: an important target for anticonvulsant drugs.
    Catterall WA
    Adv Neurol; 1999; 79():441-56. PubMed ID: 10514834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired motor function in mice with cell-specific knockout of sodium channel Scn8a (NaV1.6) in cerebellar purkinje neurons and granule cells.
    Levin SI; Khaliq ZM; Aman TK; Grieco TM; Kearney JA; Raman IM; Meisler MH
    J Neurophysiol; 2006 Aug; 96(2):785-93. PubMed ID: 16687615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats.
    Zhang XF; Shieh CC; Chapman ML; Matulenko MA; Hakeem AH; Atkinson RN; Kort ME; Marron BE; Joshi S; Honore P; Faltynek CR; Krafte DS; Jarvis MF
    Neuropharmacology; 2010 Sep; 59(3):201-7. PubMed ID: 20566409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A tryptophan residue (W736) in the amino-terminus of the P-segment of domain II is involved in pore formation in Na(v)1.4 voltage-gated sodium channels.
    Carbonneau E; Vijayaragavan K; Chahine M
    Pflugers Arch; 2002 Oct; 445(1):18-24. PubMed ID: 12397382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-limited hyperexcitability: functional effect of a familial hemiplegic migraine mutation of the Nav1.1 (SCN1A) Na+ channel.
    Cestèle S; Scalmani P; Rusconi R; Terragni B; Franceschetti S; Mantegazza M
    J Neurosci; 2008 Jul; 28(29):7273-83. PubMed ID: 18632931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small nerve fibres, small hands and small feet: a new syndrome of pain, dysautonomia and acromesomelia in a kindred with a novel NaV1.7 mutation.
    Hoeijmakers JG; Han C; Merkies IS; Macala LJ; Lauria G; Gerrits MM; Dib-Hajj SD; Faber CG; Waxman SG
    Brain; 2012 Feb; 135(Pt 2):345-58. PubMed ID: 22286749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryptogenic epileptic syndromes related to SCN1A: twelve novel mutations identified.
    Zucca C; Redaelli F; Epifanio R; Zanotta N; Romeo A; Lodi M; Veggiotti P; Airoldi G; Panzeri C; Romaniello R; De Polo G; Bonanni P; Cardinali S; Baschirotto C; Martorell L; Borgatti R; Bresolin N; Bassi MT
    Arch Neurol; 2008 Apr; 65(4):489-94. PubMed ID: 18413471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities.
    Kearney JA; Plummer NW; Smith MR; Kapur J; Cummins TR; Waxman SG; Goldin AL; Meisler MH
    Neuroscience; 2001; 102(2):307-17. PubMed ID: 11166117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Mutation in brief #957. Online.
    Vanmolkot KR; Babini E; de Vries B; Stam AH; Freilinger T; Terwindt GM; Norris L; Haan J; Frants RR; Ramadan NM; Ferrari MD; Pusch M; van den Maagdenberg AM; Dichgans M
    Hum Mutat; 2007 May; 28(5):522. PubMed ID: 17397047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant Sodium Channel Currents and Hyperexcitability of Medial Entorhinal Cortex Neurons in a Mouse Model of
    Ottolini M; Barker BS; Gaykema RP; Meisler MH; Patel MK
    J Neurosci; 2017 Aug; 37(32):7643-7655. PubMed ID: 28676574
    [No Abstract]   [Full Text] [Related]  

  • 35. Ranolazine selectively blocks persistent current evoked by epilepsy-associated Naν1.1 mutations.
    Kahlig KM; Lepist I; Leung K; Rajamani S; George AL
    Br J Pharmacol; 2010 Nov; 161(6):1414-26. PubMed ID: 20735403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders.
    Estacion M; Dib-Hajj SD; Benke PJ; Te Morsche RH; Eastman EM; Macala LJ; Drenth JP; Waxman SG
    J Neurosci; 2008 Oct; 28(43):11079-88. PubMed ID: 18945915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain.
    Liao Y; Anttonen AK; Liukkonen E; Gaily E; Maljevic S; Schubert S; Bellan-Koch A; Petrou S; Ahonen VE; Lerche H; Lehesjoki AE
    Neurology; 2010 Oct; 75(16):1454-8. PubMed ID: 20956790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Theoretical investigation of the neuronal Na+ channel SCN1A: abnormal gating and epilepsy.
    Clancy CE; Kass RS
    Biophys J; 2004 Apr; 86(4):2606-14. PubMed ID: 15041696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium channel gene expression and epilepsy.
    Noebels JL
    Novartis Found Symp; 2002; 241():109-20; discussion 120-3, 226-32. PubMed ID: 11771641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nav1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitability.
    Han C; Hoeijmakers JG; Ahn HS; Zhao P; Shah P; Lauria G; Gerrits MM; te Morsche RH; Dib-Hajj SD; Drenth JP; Faber CG; Merkies IS; Waxman SG
    Neurology; 2012 May; 78(21):1635-43. PubMed ID: 22539570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.